Orlando, Fla.—Although extracorporeal membrane oxygenation (ECMO) continues to grow in use for patients with fulminant cardiac or respiratory failure unresponsive to conventional treatment, the rescue therapy is still associated with significant morbidity and mortality, according to a team of University of Chicago Hospitals researchers. Their national database study described the characteristics of patients undergoing the procedure, as well as their readmission and survival